[go: up one dir, main page]

IN2013MU03508A - - Google Patents

Download PDF

Info

Publication number
IN2013MU03508A
IN2013MU03508A IN3508MU2013A IN2013MU03508A IN 2013MU03508 A IN2013MU03508 A IN 2013MU03508A IN 3508MU2013 A IN3508MU2013 A IN 3508MU2013A IN 2013MU03508 A IN2013MU03508 A IN 2013MU03508A
Authority
IN
India
Prior art keywords
linezolid
present
crystalline form
relates
crystallizing
Prior art date
Application number
Other languages
English (en)
Inventor
Pravin Popatrao Ghorpade
Karunesh Kumar Tiwari
Axaykumar Dave
Yogendarkumar Chauhan
Original Assignee
Unimark Remedies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unimark Remedies Ltd filed Critical Unimark Remedies Ltd
Priority to PCT/IB2014/065837 priority Critical patent/WO2015068121A1/fr
Priority to IN3508MU2013 priority patent/IN2013MU03508A/en
Publication of IN2013MU03508A publication Critical patent/IN2013MU03508A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IN3508MU2013 2013-11-06 2014-11-06 IN2013MU03508A (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/IB2014/065837 WO2015068121A1 (fr) 2013-11-06 2014-11-06 Procédé pour la préparation de la forme cristalline i de linézolide et ses compositions
IN3508MU2013 IN2013MU03508A (fr) 2013-11-06 2014-11-06

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN3508MU2013 IN2013MU03508A (fr) 2013-11-06 2014-11-06

Publications (1)

Publication Number Publication Date
IN2013MU03508A true IN2013MU03508A (fr) 2015-07-24

Family

ID=52144768

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3508MU2013 IN2013MU03508A (fr) 2013-11-06 2014-11-06

Country Status (2)

Country Link
IN (1) IN2013MU03508A (fr)
WO (1) WO2015068121A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105566242B (zh) * 2016-01-12 2017-12-05 江苏豪森药业集团有限公司 利奈唑胺及其中间体的制备方法
CN110483431A (zh) * 2019-09-04 2019-11-22 桂林南药股份有限公司 利奈唑胺杂质化合物、其制备方法以及其应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY115155A (en) 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
US5688792A (en) 1994-08-16 1997-11-18 Pharmacia & Upjohn Company Substituted oxazine and thiazine oxazolidinone antimicrobials
HUP0004388A3 (en) 1997-11-07 2001-10-29 Upjohn Co Process for the preparation of oxazolidinones, intermediates and preparation thereof
US6444813B2 (en) 2000-02-02 2002-09-03 Pharmacia & Upjohn Company Linezolid-crystal form II
DE09163348T1 (de) 2003-10-16 2010-01-07 Symed Labs Ltd., Hyderabad Kristalline Form von Linezolid
WO2006110155A1 (fr) 2004-06-29 2006-10-19 Teva Pharmaceutical Industries Ltd Formes solides du linezolide et leurs procedes de preparation
US7649096B2 (en) 2005-07-15 2010-01-19 Glenmark Pharmaceuticals Limited Process for the preparation of a crystalline form of (S)-N [[3-(3-fluoro-4(4-morpholinyl) phenyl]-2-oxo-5-oxazolidinyl] methyl] acetamide
WO2007026369A1 (fr) 2005-08-29 2007-03-08 Symed Labs Limited Nouvelle forme amorphe du linezolid
US20070197529A1 (en) 2005-12-01 2007-08-23 Viviana Braude Isolated desfluoro-linezolid, preparation thereof and its use as a reference marker and standard
CN101774978B (zh) 2009-01-13 2011-09-21 联化科技股份有限公司 一种利奈唑胺的制备方法及其中间体
WO2011050826A1 (fr) 2009-10-28 2011-05-05 Synthon B.V. Procédé de fabrication d'une forme cristalline de linézolide
CA2785620A1 (fr) 2009-12-26 2011-06-30 Alembic Pharmaceuticals Limited Procede pour la preparation de linezolide
WO2012019632A1 (fr) 2010-08-11 2012-02-16 Synthon B.V. Procédé pour fabriquer du linézolid
WO2012114354A1 (fr) 2011-02-24 2012-08-30 Lee Pharma Limited Forme ii cristalline anhydre de linézolide
WO2012119653A1 (fr) 2011-03-09 2012-09-13 Synthon Bv Procédé de préparation de la forme cristalline a du linézolid
WO2013072923A1 (fr) 2011-09-19 2013-05-23 Cadila Healthcare Limited Procédé de préparation de linézolide cristallin
WO2013093751A1 (fr) 2011-12-24 2013-06-27 Alembic Pharmaceuticals Limited Conditionnement pour le linézolide
WO2013120496A1 (fr) 2012-02-14 2013-08-22 Pharmathen S.A. Procédé pour la préparation de linézolide sous forme cristalline et de sels de celui-ci
CN102850290A (zh) 2012-10-10 2013-01-02 天津市炜杰科技有限公司 晶型i型利奈唑胺的制备方法
WO2014101064A1 (fr) * 2012-12-27 2014-07-03 上海创诺医药集团有限公司 Procédé de préparation de la forme i cristalline de linézolide

Also Published As

Publication number Publication date
WO2015068121A1 (fr) 2015-05-14

Similar Documents

Publication Publication Date Title
IN2015KN00262A (fr)
MX2021014128A (es) Polimorfos de selinexor.
PH12014000179A1 (en) New pyrrole compounds, a process for their preparation and pharmaceutical compositions containing them
MX2016012419A (es) Formas solidas de ibrutinib y procesos para la produccion de las mismas.
JO3675B1 (ar) مشتقات هيدروكسي إستر جديدة،عملية لتحضيرها وتركيبات صيدلية تحتوي عليها
EA033455B1 (ru) Кристаллические формы замещенных 5-фтор-1h-пиразолопиридинов, способы их получения, их применение для получения лекарственного средства, лекарственное средство и способ лечения на их основе
MX2016000900A (es) Nuevos derivados de indol y de pirrol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
MX360048B (es) Formas cristalinas de acido { [1-ciano-5-(4-clorofenoxi)-4-hidroxi -isoquinolin-3-carbonil]-amino}-acetico.
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
GEP201706760B (en) Novel abexinostate salt, associated crystalline form, preparation method thereof and the pharmaceutical compositions containing same
MY191352A (en) Aldosterone synthase inhibitors
IN2014MU00455A (fr)
WO2014203275A3 (fr) Procédé amélioré pour la préparation d'apixaban et de ses intermédiaires
MX2016009667A (es) Forma cristalina alfa del compuesto a monobenzoato y método de preparación de la misma y composición farmacéutica que comprende la misma.
MY186399A (en) Innovative preparation and crystallization of iosimenol
IN2013MU03508A (fr)
IL245260A0 (en) Non-aqueous crystalline form of cabazitaxel, process for its preparation and pharmaceutical compositions thereof
TN2015000095A1 (en) Macrolide derivatives, preparation thereof and therapeutic use thereof
IN2013CH04314A (fr)
TN2013000441A1 (en) 3-spirocyclic piperidine derivatives as ghrelin receptor agonists
IN2013MU02528A (fr)
IN2013MU02771A (fr)
MX370849B (es) Proceso mejorado para preparar la forma cristalina iv del posaconazol.
IN2013CH05884A (fr)
IN2013CH05769A (fr)